PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair
Yen-Chih Ho,Chen-Syun Ku,Siang-Sheng Tsai,Jia-Lin Shiu,Yi-Zhen Jiang,Hui Emmanuela Miriam,Han-Wen Zhang,Yen-Tzu Chen,Wen-Tai Chiu,Song-Bin Chang,Che-Hung Shen,Kyungjae Myung,Peter Chi,Hungjiun Liaw
DOI: https://doi.org/10.1371/journal.pgen.1010545
IF: 4.5
2022-12-15
PLoS Genetics
Abstract:Replication fork reversal which restrains DNA replication progression is an important protective mechanism in response to replication stress. PARP1 is recruited to stalled forks to restrain DNA replication. However, PARP1 has no helicase activity, and the mechanism through which PARP1 participates in DNA replication restraint remains unclear. Here, we found novel protein-protein interactions between PARP1 and DNA translocases, including HLTF, SHPRH, ZRANB3, and SMARCAL1, with HLTF showing the strongest interaction among these DNA translocases. Although HLTF and SHPRH share structural and functional similarity, it remains unclear whether SHPRH contains DNA translocase activity. We further identified the ability of SHPRH to restrain DNA replication upon replication stress, indicating that SHPRH itself could be a DNA translocase or a helper to facilitate DNA translocation. Although hydroxyurea (HU) and MMS induce different types of replication stress, they both induce common DNA replication restraint mechanisms independent of intra-S phase activation. Our results suggest that the PARP1 facilitates DNA translocase recruitment to damaged forks, preventing fork collapse and facilitating DNA repair. Replication stress induces genomic instability and is associated with cancer development. PARP1 is not only involved in base-excision repair (BER), but also restrains replication fork progression upon replication stress. However, PARP1 has no helicase activities, and the mechanism through which PARP1 participates in the formation of reversed replication forks remains unclear. In the present study, we identified novel protein-protein interactions between PARP1 and DNA translocases, including HLTF, SHPRH, ZRANB3, and SMARCAL1, with HLTF showing the strongest interaction among these DNA translocases. This finding is particularly important because PARP1 inhibitors are effective against homologous recombination deficient cancers. Our study reveals an additional function of PARP1, which restrains replication progression through interaction with DNA translocases and provides an important protective mechanism in response to replication stress.
genetics & heredity